AG Mednet CEO to Lead Zero Delay in Clinical Trials Conversation at SCOPE 2013

Pharmaceutical companies and clinical trial experts gather in Miami to discuss best practices with handling electronic data in clinical trials

Online PR News – 31-January-2013 – Miami, FL – More than half of all image-data related clinical trial query stoppages result from preventable human errors and on average can cost up to seven weeks of trial delay, millions of dollars for sponsors, and result in the potential loss of patient data. Simply speeding up the transport process does not solve the larger issue of improving data quality in these trials.

AG Mednet CEO Abraham Gutman will challenge the clinical trial industry to move closer to a zero delay world. Due to his expertise around collecting and leveraging data to optimize clinical trials, Gutman will also chair conversations regarding e-clinical solutions and electronic health records (EHR) for an audience of clinical operations executives.

SCOPE 2013 attendees will discuss:

• Current data quality and compliance challenges in clinical trials
• Technology advances that allow sites to assemble and submit quality clinical data
• Why the current clinical trial system is ready for truly disruptive changes that challenge the status quo

Who: AG Mednet CEO Abraham Gutman

What: During the Cambridge Healthtech Institute’s 4th Annual Summit for Clinical Ops Executives (SCOPE), a program designed for clinical trial decision-makers focused on improving trial outcomes, Gutman will present “Is Zero Delay achievable in the Clinical Trial Process” As part of the track addressing best practices in clinical trials. His presentation will challenge the industry to strive for zero-delay, addressing the current state of the clinical trial ecosystem, common industry misconceptions and the consequences associated with common assumptions regarding sponsors and core labs. Gutman will also serve as chairperson for two other sessions: “E-Clinical Solutions: Innovating Thoughtfully” and “Re-Use of EHR Data.”

When: Tuesday, February 5th, 2013

Where: Hyatt Regency, Miami, Fla.

To arrange an interview with Gutman prior to or at SCOPE, please call 781-893-0053 or email For more information about AG Mednet, please visit

About AG Mednet
AG Mednet automates, expedites and improves outcomes in clinical trials by ensuring quality and compliance within critical medical imaging processes. Founded in 2005, AG Mednet is the leading quality compliance partner for image data submission and collection for pharmaceutical, biotechnology and medical device companies, imaging core labs and clinical research organizations managing clinical trials globally. More than 16,000 registered users across thousands of investigator sites in 60 countries use AG Mednet to participate in projects sponsored by each of the world’s top 20 pharmaceutical, biotech and medical device companies.